在人类癌症患者和患者衍生模型中进行代谢重编程
Teresa W-M Fan1, Richard M Higashi2, Andrew N Lane2
1Center for Environmental and Systems Biochemistry; Markey Cancer Center; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky 40536, USA twmfan@gmail.com.
Cold Spring Harbor perspectives in medicine
|July 15, 2024
概括
患者衍生有机型组织培养 (PD-OTC) 和有机体 (PDO) 更好地模拟癌症.
科学领域:
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
- 癌症生物学 癌症生物学
背景情况:
- 瘤微环境 (TME) 显著影响癌症代谢重编程,影响发展和耐药性.
- 准确地建模TME对于了解癌症进展和确定治疗点至关重要.
- 在体内患者研究为评估癌症模型提供了必要的基准.
研究的目的:
- 为了比较患者衍生器官类型组织培养 (PD-OTC) 和患者衍生瘤外移植 (PDTX) 在复制体内癌症代谢重编程中的有效性.
- 评估PD-OTC和患者衍生器官 (PDO) 在研究TME依赖的代谢重编程和治疗反应中的有用性.
- 探索将PD-OTC和PDO模型与单细胞'omics相结合的潜力,以发现新的目标.
主要方法:
- 使用稳定同位素溶解代谢学来分析代谢网络.
- 患者衍生器官型组织培养 (PD-OTC) 和患者衍生瘤外移植 (PDTX) 被用作癌症模型.
- 专门研究了非小细胞肺癌模型.
主要成果:
- 与PDTXs相比,PD-OTCs显示了体内代谢重编程的优越复述.
- PD-OTCs使免疫代谢反应和TME依赖药物耐药性的审讯成为可能.
- PDO还在建模TME依赖的代谢重编程和评估治疗结果方面证明有效.
结论:
- PD-OTC和PDO是研究TME依赖癌症代谢和耐药性的有价值模型.
- 将这些模型与单细胞'omics相结合,为了解人类癌症代谢重编程提供了一种强大的方法.
- 这项研究有助于识别用于癌症治疗和药物耐药性调节的新代谢标.
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


